Author of the publication

High-Performance Interaction-Based Simulation of Gut Immunopathologies with ENteric Immunity Simulator (ENISI).

, , , , , , , , , , , and . IPDPS, page 48-59. IEEE Computer Society, (2012)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Supervised learning methods in modeling of CD4+ T cell heterogeneity., , , , , , and . BioData Min., (2015)ENISI multiscale modeling of mucosal immune responses driven by high performance computing., , , , , , , and . BIBM, page 680-684. IEEE Computer Society, (2015)Effective Social Network-Based Allocation of COVID-19 Vaccines., , , , , , , , , and 7 other author(s). KDD, page 4675-4683. ACM, (2022)Minimum Information About a Simulation Experiment (MIASE)., , , , , , , , , and 18 other author(s). PLoS Comput. Biol., (2011)Systems Modeling of Molecular Mechanisms Controlling Cytokine-driven CD4+ T Cell Differentiation and Phenotype Plasticity., , , , , , , , , and 5 other author(s). PLoS Comput. Biol., (2013)ENISI MSM: A novel multi-scale modeling platform for computational immunology., , , , , , , and . BIBM, page 391-396. IEEE Computer Society, (2014)ENISI SDE: A New Web-Based Tool for Modeling Stochastic Processes., , , , and . IEEE ACM Trans. Comput. Biol. Bioinform., 12 (2): 289-297 (2015)High Performance Agent-Based Modeling to Study Realistic Contact Tracing Protocols., , , , , , , , , and 10 other author(s). WSC, page 1-12. IEEE, (2021)Scalable Epidemiological Workflows to Support COVID-19 Planning and Response., , , , , , , , , and 2 other author(s). IPDPS, page 639-650. IEEE, (2021)Active Sensing for Epidemic State Estimation Using ABM-Guided Machine Learning., , , , and . MABS, volume 14558 of Lecture Notes in Computer Science, page 30-45. Springer, (2023)